Common Equity: The sum of all common equity items.
Radiopharm Theranostics Limited - Sponsored ADR (RADX) had Common Equity of $15.15M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$14.88M |
|
-- |
|
$25.90M |
|
$40.81M |
|
$12.82M |
|
-- |
|
$12.84M |
|
$25.66M |
|
|
Common Equity |
$15.15M |
$-10.75M |
|
$15.15M |
|
-- |
|
| Cash Flow Statement Financials | |
$-35.82M |
|
$-3.68M |
|
$22.65M |
|
$19.76M |
|
$2.81M |
|
$-16.95M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|